Nyxoah

Mont-Saint-Guibert, Belgiumnyxoah.com

Nyxoah is a medical technology company focused on developing and commercializing innovative solutions for Obstructive Sleep Apnea (OSA), the world's most common sleep disordered breathing condition. Their lead product, Genio®, is an FDA-approved and CE-Mark validated hypoglossal nerve stimulation therapy that serves as a comfortable alternative to CPAP for patients with moderate to severe OSA. Led by experienced MedTech professionals, Nyxoah has grown into a global public company through successful IPOs on Nasdaq and Euronext Brussels.